Читать книгу Practical Cardiovascular Medicine - Elias B. Hanna - Страница 235

1 71. Zellweger MJ, Kaiser C, Jeger R, et al. Coronary artery disease progression late after stent implantation. J Am Coll Cardiol 2012; 59: 793–9.

2 72. Boden WE, O’Rourke RA, Teo KK, et al. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med 2007; 356: 1503–1516. COURAGE trial.

3 73. Weintraub WS, Spertus JA, Kolm P, et al. Effect of PCI on quality of life in patients with stable coronary disease. N Engl J Med 2008; 359: 677–87.

4 74. Frye RL, August P, Brooks MM, et al.; BARI 2D Study Group. A randomized trial of therapies for type 2 diabetes and coronary artery disease. N Engl J Med 2009; 360: 2503–15.

5 75. Prasad A, Gersh BJ, Bertrand ME, et al. Prognostic significance of periprocedural versus spontaneously occurring myocardial infarction after percutaneous coronary intervention in patients with acute coronary syndromes. An analysis from the ACUITY trial. J Am Coll Cardiol 2009; 54: 477–86.

6 76. Bangalore S. Relationship of CKD severity with clinical outcomes in the ISCHEMIA and ISCHEMIA-CKD trials. Presented at ACC, March 2020.

7 77. Spertus JA, Jones PG, Maron DJ, et al. Health-status outcomes with invasive or conservative care in coronary disease. N Engl J Med 2020;382: 1408-1419. 136.